Neoprobe names new chief development officer

11/18/2010 | MedCityNews.com

Neoprobe has designated Mark Pykett as its new chief development officer. Pykett was the founder of Talaris Advisors and was chief operating officer at Alseres Pharmaceuticals. Pykett will help the company in securing approval for its tracing agent Lymphoseek, as well as determine a collaborating firm for RIGScan, another tracing agent still in early development stages.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR